 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
NEW STUDIESCARE–PlusThe BU ADC is excited to announce, CARE-Plus, a caregiver-based study which aims to reduce behavior problems in AD patients and improve caregiver’s emotional well-being. CARE-Plus is a 5-week group intervention which offers 90-minute weekly sessions on AD, its symptoms, and tips for improving communication and interactions with the family member. It also focuses on family members’ feelings about their own caregiving skills.
Flurizan IIThe BU ADC has been selected to participate in the Global Flurizan study. This is a drug study which begins this fall for people with mild AD. Enrollment is limited. Please call 617-414-1078 for information.
The ADC is pleased to announce the recipients of the 2006 Pilot Grant Awards:
Brandon Ally, PhD, Instructor of Neurology, Boston University School of Medicine, “Activation in the Posterior Association Cortex as a Therapeutic Marker.”
Isabel Carreras, PhD, Instructor of Biochemistry, Boston University School of Medicine, “Relationship between Clusterin and Abeta Aggregation in a Mouse Model of AD.” |
 |
 |
 |
 |
 |
|